|Daily Range||$29.70 - $30.42|
|52-Week Range||$19.31 - $30.74|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||203,940|
|Current FY EPS||$1.27|
Emergent BioSolutions (EBS) Description
Emergent BioSolutions makes the only FDA-approved anthrax vaccine. Website: http://www.emergentbiosolutions.com/
You don't want to miss out on these tiny biotechs expected to see earnings grow sharply in 2015.
Emergent BioSolutions Reports Positive Data on BioThrax - Analyst Blog
Catamaran Corp., Cantel Medical, and Emergent BioSolutions all gained ground during the Great Recession, suggesting that they might be good stocks to watch if markets head south.
Emergent BioSolutions' upfront payment from its deal with MorphoSys caused a large increase in revenue in the third quarter.